Document Detail


Dronedarone for atrial fibrillation?
MedLine Citation:
PMID:  21057032     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Atrial fibrillation (AF) is the commonest sustained heart arrhythmia and is associated with significant morbidity and mortality, with, for example, one in five of all strokes being attributable to the condition. Dronedarone (pronounced dro-ne-da-roan) (Multaq--sanofi-aventis) is a new anti-arrhythmic drug related to the established anti-arrhythmic amiodarone. It is licensed for use in clinically stable adult patients with a history of, or current, non-permanent AF to prevent recurrence of AF or to lower ventricular rate. Here we review its role in the management of patients with non-permanent AF.
Authors:
-
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug and therapeutics bulletin     Volume:  48     ISSN:  0012-6543     ISO Abbreviation:  Drug Ther Bull     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0112037     Medline TA:  Drug Ther Bull     Country:  England    
Other Details:
Languages:  eng     Pagination:  126-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Seasonal flu vaccination for healthcare workers?
Next Document:  Artemisinins in malaria treatment in the UK.